Spots Global Cancer Trial Database for Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation
Official Title: Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation
Study ID: NCT03490461
Conditions
Interventions
Study Description
Brief Summary: This study aims to investigate whether statin therapy can help prevent recurrence of hepatocellular carcinoma (HCC) in transplant recipients who had liver transplantation for HCC. Multiple logistic regression analysis will be performed to evaluate the association between statin therapy and the risk of HCC recurrence after LT.
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Division of Endocrinology and Metabolism Department of Internal Medicine, Yonsei University College of Medicine, Seoul, , Korea, Republic of
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
